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DISCUSSION 
 
Patients undergo surgery which results in acute pain that can put them at risk for developing chronic post-surgical pain.5 Understanding the 
mechanisms of pain transmission and plasticity and that traditional analgesic techniques may increase the risk of developing this problem is 
a key to acute peri-operative pain management.  Interrupting pain transmission via peripheral nerve blockade, pain modulation via 
glutaminergic pathway  antagonism, and pain perception with opioids and CNS depressants are keys to successful peri-op analgesia and 
avoidance of long-term pain syndromes.6  However, many medications at our disposal have short and long-term effects; both beneficial and 
adverse-opioids and α-2 agonists are two examples.5  Intravenous lidocaine and gabapentin are modalities also with evidence of short and 
long-term benefit for peri-op pain.6,7  Multi-modal analgesic techniques should be considered in all patients, weighing risk to benefit ratios, 
particularly when multiple comorbidities are present which make peri-op pain management challenging. 
REFERENCES  
1. Milan ZB, Duncan B, Rewari V, Kocarev M, Collin R. Subcostal transversus abdominis plane block for postoperative analgesia in liver transplant recipients. Transplant Proc. 2011;43:2687–90 
2. Stoelting, R. K., & Hillier, S. C. Pharmacology & Physiology in Anesthetic Practice 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2006; 167-174, 340-344.   
3. Devereaux PJ, Sessler DI. The potential role of α(2) agonists for noncardiac surgery. Anesthesiology. 2012;116(6):1192–4. 
4. Young MJ, Gorlin AW, Modest VE, Quraishi S A. Clinical implications of the transversus abdominis plane block in adults. Anesthesiol Res Pract 2012;2012:1-11 
5. Grosu I, de Kock M. New concepts in acute pain management: strategies to prevent chronic postsurgical pain, opioid-induced hyperalgesia, and outcome measures. Anesthesiol Clin 2011;29:311–27  
6. Clarke H, Bonin RP, Orser BA, Englesakis M, Wijeysundera D, Katz J. The prevention of chronic postsurgical pain using gabapentin and pregabalin: A combined systematic review and meta-analysis. Anesth Analg 2012;115:428–42  
7. Koppert W, Weigand M, Neumann F, Reinhard S, Schuettler J, Schmelz M, Werner H. Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg   2004;98:1050–5  
KETAMINE2 
•NMDA receptor antagonist 
•Amnesia/intense analgesia subanesthetic doses 
•Kappa-receptor agonist, Mu-receptor antagonist 
•Mild local anesthetic-like effect 
•Anti-inflammatory properties (inhibit IL-6) 
SIDE EFFECTS: 
•Psychomimetic side effects proportional to plasma 
concentration of ketamine 
•Sympathetic stimulation  
CLONIDINE2 
•220:1 α-2 to α-1 agonism 
•Produces sedation, hypnosis, anxiolysis, sympatholysis, 
analgesia 
•Decrease post-op narcotic & VAS scores 
•Treatment for alcohol withdrawal 
SIDE EFFECTS: 
•Prolonged hypotension, bradycardia, sedation 
•POISE-2 Trial3 (ongoing, prospective, interventional, randomized control trial) 
•Treatment with oral α-2 agonist and low dose ASA perioperatively 
•Evaluate all cause mortality & non-fatal MI at 30 days and 1 year, 




•Blocks ventral branch of T7-L1 
•Blocks spinal, ilioinguinal, iliohypogastric nerve 
•For middle/lower abdomen surgery  
•Site of injection: Triangle of Petit (iliac crest, latissimus dorsi, 
external oblique) Fig.2 
•Decrease in post-op narcotic consumption 
•Provides analgesia to abdominal wall, spares viscera 
SIDE EFFECTS: 
•Peritoneal puncture, local anesthetic toxicity, liver hematoma 
(rare) 
EO: External oblique  
IO: internal oblique 
LA: local anesthetic  
TA: transversus abdominis muscle 
CASE DESCRIPTION 
 
A 55 year old male with a history of alcoholism, smoking, mitral valve replacement on chronic anticoagulation and thrombocytopenia 
underwent laparoscopic left hepatectomy converted to laparotomy for carcinoid tumor. He received 500 micrograms of intravenous (IV) 
fentanyl  at the beginning of the case, and near the conclusion of a four hour case he received IV clonidine 40 micrograms and IV ketamine 
40 milligrams, as well as bilateral transversus abdominis plane block (TAP) with bupivicaine.  He was extubated in the operating room.  His 
PACU course required only 0.4 mg of IV hydromorphone, and phenylephrine infusion for hypotension without adverse neurologic or cardiac 
event.  The remainder of his hospital course required very minimal intravenous narcotics transitioned to oral hydrocodone. 
Fig. 2: Anatomical landmarks for triangle of Petit4 Fig. 1: Neurovascular anatomy of TAP block4 
